Certain cardiovascular effects of vasopressin (Pitressin)

Pitressin was administered intravenously in doses of 0.1 to 1 unit per kilogram of body weight either at once or during a period of thirty minutes to dogs which were anesthetized with pentobarbital sodium. Cardiac output was determined by application of the Fick principle. Systolic and diastolic blo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American heart journal 1954, Vol.47 (1), p.77-83
Hauptverfasser: Wakim, Khalil G., Denton, Clarence, Essex, Hiram E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 83
container_issue 1
container_start_page 77
container_title The American heart journal
container_volume 47
creator Wakim, Khalil G.
Denton, Clarence
Essex, Hiram E.
description Pitressin was administered intravenously in doses of 0.1 to 1 unit per kilogram of body weight either at once or during a period of thirty minutes to dogs which were anesthetized with pentobarbital sodium. Cardiac output was determined by application of the Fick principle. Systolic and diastolic blood pressures at various points in the heart or pulmonary vessels were recorded by means of strain gauges connected to cardiac catheters. Another strain gauge recorded the blood pressure from a needle inserted into the femoral artery. The blood flow was recorded in heparinized animals from one or both femoral arteries by use of bubble flowmeters. Administration of Pitressin produced definite reduction in cardiac rate, consumption of oxygen, venous content of oxygen and cardiac output. Sometimes the heart became arrhythmic, and extrasystoles appeared soon after injection of Pitressin. Initially, transient increases were noted in both systolic and diastolic blood pressures in the femoral artery. This was soon followed by increases in the systolic and diastolic pressures in the pulmonary artery, in the wedge pressure in the small pulmonary vessels, and in pressures in the left atrium, while pressures in the femoral artery decreased to less than control values and the pulse pressure was much reduced. Administration of Pitressin produced great reduction in femoral blood flow.
doi_str_mv 10.1016/0002-8703(54)90213-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75420483</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0002870354902136</els_id><sourcerecordid>75420483</sourcerecordid><originalsourceid>FETCH-LOGICAL-c358t-59c41ec142f8f1895e5749d1aba1961588875b21e0dc093c02f7b1b958b46f03</originalsourceid><addsrcrecordid>eNp9kEtLw0AQgBdRbK3-A5GcpD1Ed5J9XgQpvqCgh96XzWYWVtKm7iaC_97UFL15mgffzDAfIZdAb4CCuKWUFrmStJxzttC0gDIXR2QKVMtcSMaOyfQXmZCzlN6HUhRKnJIJlAAMZDEleomxs2GbORvr0H7a5PrGxgy9R9elrPXZ0Gt3EVMaqPlb6MZ0cU5OvG0SXhzijKwfH9bL53z1-vSyvF_lruSqy7l2DNABK7zyoDRHLpmuwVYWtACulJK8KgBp7aguHS28rKDSXFVMeFrOyPW4dhfbjx5TZzYhOWwau8W2T0ZyVlCmygFkI-him1JEb3YxbGz8MkDN3pjZ6zB7HYYz82PMiGHs6rC_rzZY_w0dFA3A3Qjg8ORnwGiSC7h1WIc4KDJ1G_6_8A2DAHj0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75420483</pqid></control><display><type>article</type><title>Certain cardiovascular effects of vasopressin (Pitressin)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Wakim, Khalil G. ; Denton, Clarence ; Essex, Hiram E.</creator><creatorcontrib>Wakim, Khalil G. ; Denton, Clarence ; Essex, Hiram E.</creatorcontrib><description>Pitressin was administered intravenously in doses of 0.1 to 1 unit per kilogram of body weight either at once or during a period of thirty minutes to dogs which were anesthetized with pentobarbital sodium. Cardiac output was determined by application of the Fick principle. Systolic and diastolic blood pressures at various points in the heart or pulmonary vessels were recorded by means of strain gauges connected to cardiac catheters. Another strain gauge recorded the blood pressure from a needle inserted into the femoral artery. The blood flow was recorded in heparinized animals from one or both femoral arteries by use of bubble flowmeters. Administration of Pitressin produced definite reduction in cardiac rate, consumption of oxygen, venous content of oxygen and cardiac output. Sometimes the heart became arrhythmic, and extrasystoles appeared soon after injection of Pitressin. Initially, transient increases were noted in both systolic and diastolic blood pressures in the femoral artery. This was soon followed by increases in the systolic and diastolic pressures in the pulmonary artery, in the wedge pressure in the small pulmonary vessels, and in pressures in the left atrium, while pressures in the femoral artery decreased to less than control values and the pulse pressure was much reduced. Administration of Pitressin produced great reduction in femoral blood flow.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/0002-8703(54)90213-6</identifier><identifier>PMID: 13114172</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Cardiovascular System - drug effects ; Humans ; Old Medline ; Vasopressins - pharmacology</subject><ispartof>The American heart journal, 1954, Vol.47 (1), p.77-83</ispartof><rights>1954</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c358t-59c41ec142f8f1895e5749d1aba1961588875b21e0dc093c02f7b1b958b46f03</citedby><cites>FETCH-LOGICAL-c358t-59c41ec142f8f1895e5749d1aba1961588875b21e0dc093c02f7b1b958b46f03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0002-8703(54)90213-6$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,4024,27923,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/13114172$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wakim, Khalil G.</creatorcontrib><creatorcontrib>Denton, Clarence</creatorcontrib><creatorcontrib>Essex, Hiram E.</creatorcontrib><title>Certain cardiovascular effects of vasopressin (Pitressin)</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>Pitressin was administered intravenously in doses of 0.1 to 1 unit per kilogram of body weight either at once or during a period of thirty minutes to dogs which were anesthetized with pentobarbital sodium. Cardiac output was determined by application of the Fick principle. Systolic and diastolic blood pressures at various points in the heart or pulmonary vessels were recorded by means of strain gauges connected to cardiac catheters. Another strain gauge recorded the blood pressure from a needle inserted into the femoral artery. The blood flow was recorded in heparinized animals from one or both femoral arteries by use of bubble flowmeters. Administration of Pitressin produced definite reduction in cardiac rate, consumption of oxygen, venous content of oxygen and cardiac output. Sometimes the heart became arrhythmic, and extrasystoles appeared soon after injection of Pitressin. Initially, transient increases were noted in both systolic and diastolic blood pressures in the femoral artery. This was soon followed by increases in the systolic and diastolic pressures in the pulmonary artery, in the wedge pressure in the small pulmonary vessels, and in pressures in the left atrium, while pressures in the femoral artery decreased to less than control values and the pulse pressure was much reduced. Administration of Pitressin produced great reduction in femoral blood flow.</description><subject>Cardiovascular System - drug effects</subject><subject>Humans</subject><subject>Old Medline</subject><subject>Vasopressins - pharmacology</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1954</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLw0AQgBdRbK3-A5GcpD1Ed5J9XgQpvqCgh96XzWYWVtKm7iaC_97UFL15mgffzDAfIZdAb4CCuKWUFrmStJxzttC0gDIXR2QKVMtcSMaOyfQXmZCzlN6HUhRKnJIJlAAMZDEleomxs2GbORvr0H7a5PrGxgy9R9elrPXZ0Gt3EVMaqPlb6MZ0cU5OvG0SXhzijKwfH9bL53z1-vSyvF_lruSqy7l2DNABK7zyoDRHLpmuwVYWtACulJK8KgBp7aguHS28rKDSXFVMeFrOyPW4dhfbjx5TZzYhOWwau8W2T0ZyVlCmygFkI-him1JEb3YxbGz8MkDN3pjZ6zB7HYYz82PMiGHs6rC_rzZY_w0dFA3A3Qjg8ORnwGiSC7h1WIc4KDJ1G_6_8A2DAHj0</recordid><startdate>1954</startdate><enddate>1954</enddate><creator>Wakim, Khalil G.</creator><creator>Denton, Clarence</creator><creator>Essex, Hiram E.</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1954</creationdate><title>Certain cardiovascular effects of vasopressin (Pitressin)</title><author>Wakim, Khalil G. ; Denton, Clarence ; Essex, Hiram E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c358t-59c41ec142f8f1895e5749d1aba1961588875b21e0dc093c02f7b1b958b46f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1954</creationdate><topic>Cardiovascular System - drug effects</topic><topic>Humans</topic><topic>Old Medline</topic><topic>Vasopressins - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wakim, Khalil G.</creatorcontrib><creatorcontrib>Denton, Clarence</creatorcontrib><creatorcontrib>Essex, Hiram E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wakim, Khalil G.</au><au>Denton, Clarence</au><au>Essex, Hiram E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Certain cardiovascular effects of vasopressin (Pitressin)</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>1954</date><risdate>1954</risdate><volume>47</volume><issue>1</issue><spage>77</spage><epage>83</epage><pages>77-83</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><abstract>Pitressin was administered intravenously in doses of 0.1 to 1 unit per kilogram of body weight either at once or during a period of thirty minutes to dogs which were anesthetized with pentobarbital sodium. Cardiac output was determined by application of the Fick principle. Systolic and diastolic blood pressures at various points in the heart or pulmonary vessels were recorded by means of strain gauges connected to cardiac catheters. Another strain gauge recorded the blood pressure from a needle inserted into the femoral artery. The blood flow was recorded in heparinized animals from one or both femoral arteries by use of bubble flowmeters. Administration of Pitressin produced definite reduction in cardiac rate, consumption of oxygen, venous content of oxygen and cardiac output. Sometimes the heart became arrhythmic, and extrasystoles appeared soon after injection of Pitressin. Initially, transient increases were noted in both systolic and diastolic blood pressures in the femoral artery. This was soon followed by increases in the systolic and diastolic pressures in the pulmonary artery, in the wedge pressure in the small pulmonary vessels, and in pressures in the left atrium, while pressures in the femoral artery decreased to less than control values and the pulse pressure was much reduced. Administration of Pitressin produced great reduction in femoral blood flow.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>13114172</pmid><doi>10.1016/0002-8703(54)90213-6</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-8703
ispartof The American heart journal, 1954, Vol.47 (1), p.77-83
issn 0002-8703
1097-6744
language eng
recordid cdi_proquest_miscellaneous_75420483
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Cardiovascular System - drug effects
Humans
Old Medline
Vasopressins - pharmacology
title Certain cardiovascular effects of vasopressin (Pitressin)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T12%3A37%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Certain%20cardiovascular%20effects%20of%20vasopressin%20(Pitressin)&rft.jtitle=The%20American%20heart%20journal&rft.au=Wakim,%20Khalil%20G.&rft.date=1954&rft.volume=47&rft.issue=1&rft.spage=77&rft.epage=83&rft.pages=77-83&rft.issn=0002-8703&rft.eissn=1097-6744&rft_id=info:doi/10.1016/0002-8703(54)90213-6&rft_dat=%3Cproquest_cross%3E75420483%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75420483&rft_id=info:pmid/13114172&rft_els_id=0002870354902136&rfr_iscdi=true